Bile
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Canned medical bile has a local irritant effect.
Indications
Arthralgia; post-traumatic myalgia (without compromising the integrity of the skin).
Composition
1 bottle contains:
Active substance: canned cattle and pig bile;
Excipients: rectified ethyl alcohol, formalin, furatsillina solution in 70% alcohol, perfume
No customer reviews for the moment.
Dosage and Administration
Medical bile is used externally. In the form of compresses for 6-10 days.
Gauze napkin (4-6 layers) is plentifully impregnated with the preparation. The napkin is applied to the affected area, covered with waxed paper, a thin layer of cotton and fixed with a light bandage. Holds for a day. When drying, the gauze cloth is moistened with water at room temperature and fixed again with a bandage. A day later, the compresses are replaced with the obligatory new gauze napkin.
Adverse reactions
In rare cases, canned medical bile can cause skin irritation, which quickly disappears when the drug is withdrawn.
In such cases, the subsequent use of compresses is possible only after 30 days.
Contraindications
- Diagnosed hypersensitivity to the drug. Canned medical bile.
- Violations of the integrity of the skin in the field of the intended application of the drug.
- Skin diseases
- Brand name: Canned medical bile
- Active ingredient: Bile
- Dosage form: Emulsion for external use
- Manufacturer: Samson-Med OAO
- Country of Origin: Russia
Studies and clinical trials of Bile (Click to expand)
- Urinary bile acids and peroxisomal bifunctional enzyme deficiency
- How I do it: Thermal bile duct protection during liver cryoablation
- Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987–1991
- Synchronous primary tumors of the extrahepatic bile duct and gallbladder
- K-ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters
- Choledochojejunostomy with invagination of the bile duct into the jejunum
- Diagnostic and prognostic value of incidence of k-ras codon 12 mutations in resected distal bile duct carcinoma
- Aberrations of the K-ras,p53, andAPC genes in extrahepatic bile duct cancer
- Prevention of postoperative bile leakage after major hepatic resections in malignancies
- Effect of metformin on bile salt circulation and intestinal motility in Type 2 diabetes mellitus
- Separatory Determination of Bile Acid 3-Sulfates by Liquid Chromatography/Electrospray Ionization Mass Spectrometry
- THREE-DIMENSIONAL RECONSTRUCTION OF PERINEURAL INVASION IN CARCINOMA OF THE EXTRAHEPATIC BILE DUCTS
- Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study
- Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis
- Imaging supramolecular aggregates in bile models and human bile
- Development and differentiation of bile ducts in the mammalian liver
- Development and maintenance of bile canaliculi in vitro and in vivo
- Sonographically visible intrahepatic bile ducts in healthy elderly
- In vitro sonographic evaluation of common bile duct stones and fragments with a high-frequency microprobe
- A study on biliary ductal system and bile fistula in the American alligator,Alligator mississippiensis
- Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct
- Lack of CD44 variant 6 expression in advanced extrahepatic bile duct/ampullary carcinoma
- Carcinoid tumors of the extrahepatic bile duct : A rare cause of malignant biliary obstruction
- Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis